karen boezi

Karen Boezi is a member of Broadway Angels and the founding managing director of QB3's Executive Mentorship Program. She's also a co-founder of the new San Francisco Girls' School and Center of Excellence for Girls' STEM Education initiatives. Previously, Karen was the CEO of Redwood Bioscience which she joined as the first non-founder employee, leading the company through its successful acquisition by Catalent (CTLT). Redwood, now Catalent Biologics, continues to be a pioneer in developing therapeutic conjugate technology and antibody-drug conjugates for improving cancer treatment. Prior to joining Redwood, Karen was a co-founder and partner of Thomas, McNerney & Partners (TMP), a health care technology-focused venture firm with $600 million under management. TMP was recently recognized for managing one of the top three performing 2006 vintage venture funds globally. Previously, she was a General Partner of Coral Ventures and a member of Warburg Pincus LLC’s healthcare technology venture group. During her venture career, Karen was involved with 15 companies from initial investment that went public and/or were acquired; three of which she launched in collaboration with scientific founders. Karen began her career as a member of Alex. Brown & Sons’s health care and insurance corporate finance teams. She graduated Phi Beta Kappa and magna cum laude with a B.S. in Economics from the Wharton School at the University of Pennsylvania.

Karen Boezi

VC

Overview

Investments

Ellevest

Articles About Karen

Relevant Websites